✦ LIBER ✦
A phase II trial of human recombinant lnterleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study
✍ Scribed by Madeline Bauer; Gregory H. Reaman; Jacquelyn A. Hank; Mitchell S. Cairo; Peter Anderson; Bruce R. Blazar; Sharon Frierdich; Paul M. Sondel
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 619 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.